Editorial & Opinion
Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply.
| العنوان: | Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply. |
|---|---|
| المؤلفون: | Burghart L; Klinik Ottakring, Wiener Gesundheitsverbund, Vienna, Austria.; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria., Hofer BS; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Halilbasic E; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Simbrunner B; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Staettermayer AF; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Trauner M; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Reiberger T; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. |
| المصدر: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jul; Vol. 60 (1), pp. 107-108. Date of Electronic Publication: 2024 May 27. |
| نوع المنشور: | Letter; Comment |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Oxford : Wiley-Blackwell Original Publication: [Oxford, OX] : Blackwell Scientific Publications, [c1987- |
| مواضيع طبية MeSH: | Liver Cirrhosis*/drug therapy , Liver Cirrhosis*/complications, Humans ; Liver Cirrhosis, Biliary/drug therapy ; Liver Cirrhosis, Biliary/complications ; Hypolipidemic Agents/therapeutic use ; Hypolipidemic Agents/adverse effects ; Fibric Acids/therapeutic use ; Cholangitis/drug therapy |
| التعليقات: | Comment on: Aliment Pharmacol Ther. 2024 Jul;60(1):105-106. doi: 10.1111/apt.18044. (PMID: 38803269) |
| References: | Ao X, Zeng Y, Wang X, Fan X. Letter: fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis. Aliment Pharmacol Ther. 2024;60:105–106. Lammers WJ, van Buuren HR, Hirschfield GM, Janssen HL, Invernizzi P, Mason AL, et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow‐up study. Gastroenterology. 2014;147(6):1338–1349.e5. Tanaka A, Hirohara J, Nakano T, Matsumoto K, Chazouillères O, Takikawa H, et al. Association of bezafibrate with transplant‐free survival in patients with primary biliary cholangitis. J Hepatol. 2021;75:565–571. Hofer BS, Burghart L, Halilbasic E, Simbrunner B, Petrenko O, Mandorfer M, et al. Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Aliment Pharmacol Ther. 2024;59:962–972. |
| المشرفين على المادة: | 0 (Hypolipidemic Agents) 0 (Fibric Acids) |
| تواريخ الأحداث: | Date Created: 20240528 Date Completed: 20240611 Latest Revision: 20240710 |
| رمز التحديث: | 20240710 |
| DOI: | 10.1111/apt.18067 |
| PMID: | 38803242 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.18067 |